Analyst firms · Morgan Stanley · NVRO

Morgan Stanley NVRO price target and rating history

Nevro Corp. (NVRO) · Health Care

Morgan Stanley rates Nevro Corp. (NVRO) Underweight with a $4 price target, as of its latest action on Dec 2, 2024. It has published 4 rating actions on NVRO since August 2021, including 0 upgrades and 2 downgrades.

Current rating
Underweight
Price target
$4
Median target, all firms
Too few
Actions on NVRO
4

Morgan Stanley price target on NVRO

$150$77$420222023202420252026
Morgan Stanley price target on NVRO, each point a stated target, August 2021 to December 2024.

Every Morgan Stanley rating on NVRO

Questions about Morgan Stanley and NVRO

What is Morgan Stanley's price target for NVRO?
Morgan Stanley's latest stated price target for Nevro Corp. (NVRO) is $4, from its action on Dec 2, 2024.
What is Morgan Stanley's rating on NVRO?
Morgan Stanley rates NVRO Underweight, a bearish rating, as of Dec 2, 2024.
When did Morgan Stanley last change its view on NVRO?
On Dec 2, 2024, Morgan Stanley downgrades to Underweight from Equal-Weight, price target $9 to $4.

More NVRO rating histories

All Morgan Stanley ratingsNVRO news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.